CU22694A1 - Preparación vacunal basada en la obtención y caracterización del antígeno bm95 de boophilus microplus - Google Patents
Preparación vacunal basada en la obtención y caracterización del antígeno bm95 de boophilus microplusInfo
- Publication number
- CU22694A1 CU22694A1 CU1998024A CU1998024A CU22694A1 CU 22694 A1 CU22694 A1 CU 22694A1 CU 1998024 A CU1998024 A CU 1998024A CU 1998024 A CU1998024 A CU 1998024A CU 22694 A1 CU22694 A1 CU 22694A1
- Authority
- CU
- Cuba
- Prior art keywords
- vaccine preparation
- boophilus microplus
- characterization
- obtaining
- antigen
- Prior art date
Links
- 239000000427 antigen Substances 0.000 title abstract 3
- 108091007433 antigens Proteins 0.000 title abstract 3
- 102000036639 antigens Human genes 0.000 title abstract 3
- 241000238680 Rhipicephalus microplus Species 0.000 title abstract 2
- 238000002360 preparation method Methods 0.000 title abstract 2
- 229960005486 vaccine Drugs 0.000 title abstract 2
- 238000012512 characterization method Methods 0.000 title 1
- 241000238876 Acari Species 0.000 abstract 1
- 241000235058 Komagataella pastoris Species 0.000 abstract 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 abstract 1
- 238000010367 cloning Methods 0.000 abstract 1
- 238000010353 genetic engineering Methods 0.000 abstract 1
- 238000002955 isolation Methods 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
- 201000001064 tick infestation Diseases 0.000 abstract 1
Landscapes
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
Abstract
La presente invención se relaciona con la Ingeniería Genética y la Biotecnología y en particular con el aislamiento de un nuevo gen de la garrapata Boophilus microplus, su clonación y expresión en la levadura Pichia pastoris, así como la preparación vacunal que contiene al antígeno en forma glicosilada y particulada y su uso para el control de infestaciones de garrapatas. Este nuevo antígeno es efectivo frente a diferentes cepas de garrapatas.
Priority Applications (6)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CU1998024A CU22694A1 (es) | 1998-02-20 | 1998-02-20 | Preparación vacunal basada en la obtención y caracterización del antígeno bm95 de boophilus microplus |
| ZA9901320A ZA991320B (en) | 1998-02-20 | 1999-02-18 | BM95 antigen of the cattle tick boophilus microplus, isolation, sequence, recombinant molecules, transformed microorganisms and vaccine preparations. |
| CO99010371A CO4820441A1 (es) | 1998-02-20 | 1999-02-19 | Antigeno bm 95 de la garrapata boophilus microplus, aislamiento, secuencia, adn recombinantes, microorganismos transformados y preparacion vacunal |
| UY25393A UY25393A1 (es) | 1998-02-20 | 1999-02-22 | Antígeno bm95 de la garrapata boophilus microplus, aislamiento, secuencia, adn recombinante, microorganismos transformados y preparación vacunal |
| BR9900780-0A BR9900780A (pt) | 1998-02-20 | 1999-02-22 | Imunogene, sequência de dna, molécula recombinante de dna, transformante de qualquer linhagem celular, produto de expressão, procedimento para a produção de antìgeno bm95 na levedura pichia pastoris, ppbma de dna recombinante, microorganismo transformado bma2, e, preparação de vacina |
| ARP990100715 AR018103A1 (es) | 1998-02-20 | 1999-02-23 | ANTíGENO BM95 DE LA GARRAPATA BOOPHILUS MICROPLUS, AISLAMIENTO, SECUENCIA, ADN RECOMBINANTES, MICROORGANISMOS TRANSFORMADOS Y PREPARACIoN VACUNAL. |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CU1998024A CU22694A1 (es) | 1998-02-20 | 1998-02-20 | Preparación vacunal basada en la obtención y caracterización del antígeno bm95 de boophilus microplus |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CU22694A1 true CU22694A1 (es) | 2001-07-31 |
Family
ID=5459219
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CU1998024A CU22694A1 (es) | 1998-02-20 | 1998-02-20 | Preparación vacunal basada en la obtención y caracterización del antígeno bm95 de boophilus microplus |
Country Status (6)
| Country | Link |
|---|---|
| AR (1) | AR018103A1 (es) |
| BR (1) | BR9900780A (es) |
| CO (1) | CO4820441A1 (es) |
| CU (1) | CU22694A1 (es) |
| UY (1) | UY25393A1 (es) |
| ZA (1) | ZA991320B (es) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BR102013026625B1 (pt) | 2013-10-16 | 2022-04-26 | Universidade Federal de Viçosa | Vacina de peptídeos recombinantes para o controle de carrapatos e sequências de nucleotídeos codificadoras dos peptídeos recombinantes |
-
1998
- 1998-02-20 CU CU1998024A patent/CU22694A1/es unknown
-
1999
- 1999-02-18 ZA ZA9901320A patent/ZA991320B/xx unknown
- 1999-02-19 CO CO99010371A patent/CO4820441A1/es unknown
- 1999-02-22 UY UY25393A patent/UY25393A1/es not_active Application Discontinuation
- 1999-02-22 BR BR9900780-0A patent/BR9900780A/pt not_active IP Right Cessation
- 1999-02-23 AR ARP990100715 patent/AR018103A1/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| UY25393A1 (es) | 1999-09-27 |
| CO4820441A1 (es) | 1999-07-28 |
| ZA991320B (en) | 1999-08-19 |
| AR018103A1 (es) | 2001-10-31 |
| BR9900780A (pt) | 2001-03-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATA10002000A (de) | Antigene zusammensetzung | |
| WO2007091030A3 (en) | Peptide sequences and compositions | |
| NZ597401A (en) | Chimeric influenza virus-like particles comprising hemagglutinin | |
| ES2534744T3 (es) | Plasmina modificada de forma recombinante | |
| MX2009006594A (es) | Formulaciones de ph regulado y estables que contienen polipeptidos. | |
| NZ600690A (en) | Fkbp-l and uses thereof | |
| WO2009046220A3 (en) | Lipopeptides for delivery of nucleic acids | |
| MX346865B (es) | Vacuna de virus de varicela zoster. | |
| TW200602083A (en) | Hair cosmetic composition. | |
| SG178797A1 (en) | Oligosaccharide chain added glp-1 peptide | |
| WO2005108546A3 (en) | Stirred-tank reactor system | |
| DE60210772D1 (de) | Verfahren zur herstellung von l-aminosäuren unter verwendung von stämmen der familie enterobacteriaceae | |
| NZ607224A (en) | Non-lipidated variants of neisseria meningitidis orf2086 antigens | |
| DK1608336T3 (da) | Formulering til en doseringsinhalator med hydrofluorakaner som drivmidler | |
| WO2007066334A9 (en) | Improved influenza vaccine | |
| AR067980A1 (es) | Peptidos de cdh3 y agentes que los comprenden | |
| AR070491A1 (es) | Variante de enzima lipolitica con estabilidad aumentada y polinucleotidos que la codifican | |
| AR052056A1 (es) | Tratamiento antiangiogenico de enfermedades autoinmunitarias en pacientes que no han respondido a untratamiento previo | |
| PE20120400A1 (es) | Contrucciones de casb7439 | |
| BRPI0715331B8 (pt) | polipeptídeo que compreende uma porção n-terminal e uma porção c-terminal, e uso do mesmo | |
| NZ594268A (en) | Grass peptides for vaccine | |
| ATE453664T1 (de) | Hausstaubmilbenallergen | |
| AU2002310474A1 (en) | Multiple antigenic peptide displaying multiple copies of an epitope of plaque-forming polypeptide and methods of using same | |
| CU22694A1 (es) | Preparación vacunal basada en la obtención y caracterización del antígeno bm95 de boophilus microplus | |
| BR0309491A (pt) | Composição de vacina, composição imunogênica, utilização de uma proteìna e7 e anticorpos neutralizantes |